(Bloomberg News) -- IBM is furthering the expansion of its Watson data-analytics technology into health care through partnerships around human gene analysis and cancer treatment.
International Business Machines Corp. is working with 14 cancer institutes, including Yale Cancer Center, to use Watson to identify cancer-causing mutations and help tailor treatments. IBM also said Tuesday that it is teaming up with software maker Epic Systems Corp. and the Mayo Clinic to analyze patients’ electronic health-care records.
Register or login for access to this item and much more
All Information Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access